DexCom

Youtube Subscribe

Open: 130.98 Close: 130.6 Change: -0.38

You don't have time to read all about DexCom Stock. An AI summarizes all the information for you.

This document will help you to evaluate DexCom without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about DexCom are: Dexcom, DexCom, melbn, CGM, DXCM, price, revenue, and the …

Concept Map

Semantic Network

Stock Summary

DexCom, Inc. focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems. The company provides its systems for use by people with diabetes, as well as for use. Dexcom G6.

Today's Summary

DexCom (DXCM) closed at $130.60 in the latest trading session, marking a -0.04% move from the prior day. With a volume of 1,284,261, the price of DXCM is down -3.02% at $133.76. DexCom recorded revenue of $7.45 billion, exceeding the anticipated $720 million figure.

Today's News

DexCom (DXCM) closed at $130.60 in the latest trading session, marking a -0.04% move from the prior day. With a volume of 1,284,261, the price of DXCM is down -3.02% at $133.76. DexCom is holding a Zacks Rank of #2 (Buy) right now. DexCom recorded revenue of $7.45 billion, exceeding the anticipated $720.52 million figure. DexCom boasts a net margin of 9.68%, indicating its proficiency in managing costs and maintaining profitability. Institutional investors and hedge funds own an overwhelming majority of DexCom stock. The correct way to pronounce the word Melbourne is? Mel-bn mel-bn. me-lbn me- lbn melbn melbon melbn. Dexcom reported expected full-year 2021 revenues of $2.48B, a growth of 27% over 2020. Dexcom devices are compatible with a wide range of insulin pens. Some smart insulin pens and Dexcom CGM systems allow seamless integration and data syncing. By analyzing data from both the smart insulin pen and the Dexcom system, users can gain personalized insights. The Wall Street Transcript: DexCom, Inc. - the wall street transcript. Dexcom stock has gained 139% since 2019 primarily due to favorable change in revenues. Some individuals with commercial insurance can currently purchase Dexcom G7 for a “special” rate of $89 per month. DexCom has taken significant steps to understand its carbon footprint and track greenhouse gas emissions. In 2022, DexComs GHG emissions increased compared to the previous year. Dexcom is a pioneering company that has revolutionized the field of continuous glucose monitoring (CGM) for individuals living with diabetes. Founded in 1999, Dexcom has emerged as a leading player. Dexcom has embraced the trend of digital health and integration of CGM technology with various mobile platforms and health-related applications. The company continues to push the boundaries of the technology. Dexcom G7 overpatch is extremely frustrating. The sensor size is definitely improved and I havent had any issues with it falling off even in extreme heat and excess water. Dexcom officially only supports 3.0. Dexcom CGM adhesive - Mix Pack Suits G4/G5 & G6 - is hypoallergenic and latex oxide free. Dexcom Inc is Overvalued by 70% compared to the current market price of 130.6 USD. Wall Street analysts forecast DXCM stock price to rise over the next 12 months. The higher the solvency score, the more solvent the company is. Dexcom G6 Continuous Glucose Monitoring System is a real-time, continuous glucose monitoring device indicated for the management of diabetes in persons age 2.

Stock Profile

"DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices for specific and permitted use cases, including non-medical device applications, medical device data analysis, integrated continuous glucose monitoring systems (iCGM) secondary display alarms, active patient monitoring, and treatment decisions; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California."

Keywords

The game is changing. There is a new strategy to evaluate DexCom fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about DexCom are: Dexcom, DexCom, melbn, CGM, DXCM, price, revenue, and the most common words in the summary are: dexcom, g6, stock, market, price, cgm, year, . One of the sentences in the summary was: DexCom (DXCM) closed at $130.60 in the latest trading session, marking a -0.04% move from the prior day. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #dexcom #g6 #stock #market #price #cgm #year.

Read more →

Youtube Subscribe

---